MedTrace Logo

MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY

NCT05915364 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-06-23

No results posted yet for this study

Summary

The MAGIC-HF STUDY project (MAgna GraecIa evaluation of Comorbidities in patients with Heart Failure STUDY), is an observational prevalence and incidence study focusing on the role that risk factors, various comorbidities, and their treatment may have on CV and non-CV outcomes in patients with all forms of HF. It also aim to assess whether comorbidities and their treatment may be predictors of response to pharmacological and non-drug treatment of HF.

Conditions

Sponsors & Collaborators

  • University of Catanzaro

    lead OTHER

Principal Investigators

  • Angela Sciacqua, MD · University of Catanzaro

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-06-01
Completion
2024-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05915364 on ClinicalTrials.gov